Lise Rochaix

ORCID: 0000-0002-6467-0332
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Health Systems, Economic Evaluations, Quality of Life
  • Healthcare Systems and Practices
  • Healthcare Policy and Management
  • Global Health Care Issues
  • Pharmaceutical Economics and Policy
  • Health, Medicine and Society
  • Social Sciences and Governance
  • Pharmaceutical industry and healthcare
  • Social Policies and Family
  • Employment and Welfare Studies
  • Global Cancer Incidence and Screening
  • Health disparities and outcomes
  • Economic and Environmental Valuation
  • Health Services Management and Policy
  • Migration, Identity, and Health
  • Pharmaceutical studies and practices
  • Cervical Cancer and HPV Research
  • Workplace Health and Well-being
  • Primary Care and Health Outcomes
  • Public Health Policies and Education
  • Health Policy Implementation Science
  • Clinical practice guidelines implementation
  • Occupational Health and Safety Research
  • French Urban and Social Studies
  • Blood Pressure and Hypertension Studies

Paris School of Economics
2010-2024

Université Paris 1 Panthéon-Sorbonne
2014-2024

Nutrition et obésité : approches systémiques
2017-2023

Paris Jourdan Sciences Economiques
2020-2023

Assistance Publique – Hôpitaux de Paris
2017-2023

Université Paris Cité
1994-2022

Ministère de l’Environnement et du Développement Durable
2022

Université Sorbonne Nouvelle
2019

New York University Press
2018

Cambridge University Press
2018

Context: The discussion about improving the efficiency, quality, and long‐term sustainability of U.S. health care system is increasingly focusing on need to provide better evidence for decision making through comparative effectiveness research (CER). In recent years, several other countries have established agencies evaluate technologies broader management strategies inform policy decisions. This article reviews experiences from Britain, France, Australia, Germany. Methods: draws experience...

10.1111/j.1468-0009.2009.00560.x article EN Milbank Quarterly 2009-06-01

10.1016/0167-6296(89)90009-x article EN Journal of Health Economics 1989-03-01

Seventy-five percent of patients with beta thalassemia (β-thalassemia) do not have human leukocyte antigen-matched siblings and until recently had no access to a curative treatment. Gene therapy is promising treatment that can be proposed these patients. This study estimates its cost efficacy. In monocentric retrospective cost-efficacy analysis, this compared the two-year outcomes costs β-thalassemia treated by gene hematopoietic stem-cell transplantation (HSCT). Grade III grade IV...

10.1089/hum.2018.178 article EN Human Gene Therapy 2019-01-31

Abstract Background This study aimed to investigate the status of cervical cancer screening (CCS) implementation in Europe by investigating national or regional policies towards broadening coverage CCS amongst vulnerable subgroups population at high risk for CC. Methods A web-based survey was conducted between September 2021 and February 2022 with programme managers experts identify rank six considered most CC map existing that addressed sub-groups risk. Results total 31 responses were...

10.1093/eurpub/ckad055 article EN cc-by-nc European Journal of Public Health 2023-04-12

Cervical cancer remains a significant public health concern in Europe. Effective introduction and scaling up of human papillomavirus (HPV) detection-based cervical screening (CCS) requires systematic assessment systems capacity. However, there is no validated capacity methodology for CCS programmes, especially European contexts. Addressing this gap, our study introduces an innovative adaptable protocol evaluating the programmes across varying system settings. Our research team developed...

10.1186/s12961-024-01190-y article EN cc-by-nc-nd Health Research Policy and Systems 2024-08-12

In this article, we assess the recent performance of French state at containing costs in health care using political science concepts such as path dependency and incentives, which are central to an economic approach. The article focuses on institutional capacities cultural immobilism attempts lay bare tensions play seizing (or not) opportunities for structural change. particular, attempt delineate what constitutes real change policy arena (big reforms versus accumulation many small...

10.1215/03616878-30-1-2-97 article EN Journal of Health Politics Policy and Law 2005-04-01

Résumé Alors que de nombreuses recherches récentes ont apporté des éléments mesure, voire d’explication inégalités sociales santé et recours aux soins en France, leurs aspects relevant l’équité n’ont pas été systématiquement mis avant. Cet article pose la question du statut dans le contexte actuel travaux empiriques propose une lecture éthique domaine santé, tant économiques qu’épidémiologiques, particulièrement celles qui relèvent demande santé. Nous considérons les sous-jacents à mesure...

10.3917/reco.602.0325 article FR Revue économique 2009-03-30

Asymétries d'information et incertitude en santé : les apports de la théorie des contrats par Lise Rochaix Le caractère imparfait, voire asymétrique, l'information dont dispose le patient conduit à remettre cause l'utilisation du modèle néoclassique standard appliquer modèles micro-économiques type Principal - Agent. L'objet cet article est dresser un bilan applications récentes au secteur contrats. Si cette dernière offre une grille lecture pertinente, elle toutefois demeurée peu...

10.3406/ecop.1997.5861 article FR Économie & prévision 1997-01-01

The Induced Demand Hypothesis: an Economic Assessment by Lise Rochaix and Stéphane Jacobzone In health economics the induced demand hypothesis is bringing about a transformation in way health-care perceived. It posits that does not simply reflect choice terms of patient utility but can also be determined doctor's implicit motivation. This extremely polemical has formed basis for numerous empirical studies. this paper we demonstrate controversy arises partly from exact formulation hypothesis....

10.3406/ecop.1997.5862 article EN Économie & prévision 1997-01-01

Abstract Do Primary Care Physicians (PCPs) react strategically to financial incentives and if so how? To address this question, we follow a quasi‐natural experiment in Quebec, using panel system technique. In doing, both correct for underestimation biases earlier time series findings generate new results on the issue of complementarity/substitution between consultations with varying levels technicality. Under techniques, show that PCPs are sensitive enforcement subsequent temporary removals...

10.1002/hec.1012 article EN Health Economics 2005-09-15

Abstract Background Spread of resistant bacteria causes severe morbidity and mortality. Stringent control measures can be expensive disrupt hospital organization. In the present study, we assessed effectiveness cost-effectiveness strategies to prevent spread Carbapenemase-producing Enterobacterales (CPE) in a general ward (GW). Methods A dynamic, stochastic model simulated transmission CPE by hands healthcare workers (HCWs) environment hypothetical 25-bed GW. Input parameters were based on...

10.1186/s13756-022-01149-0 article EN cc-by Antimicrobial Resistance and Infection Control 2022-09-19

This paper presents an empirical investigation of physician labour supply, based on a two-stage budgeting model, drawing analogy with consumer theory. Physicians' trade-offs between income and leisure constitute the first stage decision-making process. In turn, choices are made in second concerning choice particular activities (hospital versus office care, for example) or procedures (ordinary complete medical examinations), given total care activity chosen stage. The objective study is to...

10.1002/hec.4730020209 article EN Health Economics 1993-07-01

We examine provider and patient behavior in a dynamic model where effort is noncontractible, competition between providers modeled an explicit way patients' outside options are solved for equilibrium. Physicians characterized by individual‐specific ethical constraint which allows unobserved heterogeneity. This introduces uncertainty the patient's expected treatment if he were to leave his current physician seek care elsewhere. also introduce switching costs treatment–outcome relationship....

10.1111/j.1530-9134.2009.00220.x article EN Journal of Economics & Management Strategy 2009-04-28

10.1016/j.jeem.2020.102338 article EN publisher-specific-oa Journal of Environmental Economics and Management 2020-05-20

10.1007/s10258-003-0019-2 article EN Portuguese Economic Journal 2003-08-01
Coming Soon ...